Peter J. Zimetbaum
Corporate Officer/Principal at Harvard Medical School
Profile
Peter J.
Zimetbaum is currently the Director-ECG & Arrhythmia Core Laboratory at The Baim Institute for Clinical Research and an Associate Professor-Medicine at Harvard Medical School since 2006.
He was previously the Director at Forest Laboratories, Inc. from 2009 to 2011 and the Director-Clinical Cardiology at Beth Israel Deaconess Medical Center, Inc. He received his doctorate degree from Albert Einstein College of Medicine, Inc. in 1990.
Peter J. Zimetbaum active positions
Companies | Position | Start |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | 2010-07-27 |
The Baim Institute for Clinical Research
The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Former positions of Peter J. Zimetbaum
Companies | Position | End |
---|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
FOREST LABORATORIES, INC. | Director/Board Member | - |
Training of Peter J. Zimetbaum
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
The Baim Institute for Clinical Research
The Baim Institute for Clinical Research Miscellaneous Commercial ServicesCommercial Services The Baim Institute for Clinical Research manages clinical trial data in a range of therapeutic areas for commercial, academic, and scientific purposes. The firm engages in the design, management, and data analysis of clinical trials in the U.S. and internationally. It offers clinical CRO services that include trial design, project management, site management and monitoring, statistical analysis, medical monitoring and oversight, clinical endpoint event identification and adjudication and medical writing services; and data management, including electronic data capture services. The company was founded by Donald S. Baim and Richard E. Kuntz in 1993 and is headquartered in Boston, MA. | Commercial Services |
- Stock Market
- Insiders
- Peter J. Zimetbaum